Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa.

Yatim A, Bohelay G, Grootenboer-Mignot S, Prost-Squarcioni C, Alexandre M, Le Roux-Villet C, Martin A, Maubec E, Caux F.

Front Med (Lausanne). 2019 Nov 5;6:249. doi: 10.3389/fmed.2019.00249. eCollection 2019.

2.

P63-related disorders: Dermatological characteristics in 22 patients.

Maillard A, Alby C, Gabison E, Doan S, Caux F, Bodemer C, Hadj-Rabia S.

Exp Dermatol. 2019 Oct;28(10):1190-1195. doi: 10.1111/exd.14045.

PMID:
31585491
3.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
4.

Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.

Javaud N, Soria A, Maignan M, Martin L, Descamps V, Fain O, Bouillet L, Berard F, Tazarourte K, Roy PM, Fontaine JP, Bagot M, Khellaf M, Goulet H, Lapostolle F, Casalino E, Doutre MS, Gil-Jardine C, Caux F, Chosidow O, Pateron D, Vicaut E, Adnet F.

BMJ Open. 2019 Aug 21;9(8):e027431. doi: 10.1136/bmjopen-2018-027431.

5.

Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma.

Cǎlugǎreanu A, Rompteaux P, Bohelay G, Goldfarb L, Barrau V, Cucherousset N, Heidelberger V, Nault JC, Ziol M, Caux F, Maubec E.

Immunotherapy. 2019 Aug;11(12):1005-1013. doi: 10.2217/imt-2019-0077. Epub 2019 Jul 15.

PMID:
31304833
6.

Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up.

Rousseau A, Prost-Squarcioni C, Doan S, Leroux-Villet C, Caux F, Hoang-Xuan T, Cochereau I, Gabison E.

Br J Ophthalmol. 2020 Feb;104(2):235-240. doi: 10.1136/bjophthalmol-2019-313960. Epub 2019 May 14.

PMID:
31088794
7.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
8.

Factors associated with relapses among patients treated for acute urticaria.

Maillet F, Wolff D, Soria A, Adnet F, Panayotopoulos V, Gobert D, Lapostolle F, Reuter PG, Ghazali A, Caux F, Fain O, Javaud N.

J Dermatol. 2019 May;46(5):383-388. doi: 10.1111/1346-8138.14830. Epub 2019 Feb 28.

PMID:
30816579
9.

[What's new in research?]

Caux F.

Ann Dermatol Venereol. 2018 Dec;145 Suppl 7:VIIS17-VIIS23. doi: 10.1016/S0151-9638(18)31285-7. Review. French.

PMID:
30583753
10.

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B.

Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4.

PMID:
30511379
11.

Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Zumelzu C, Alexandre M, Le Roux C, Weber P, Guyot A, Levy A, Aucouturier F, Mignot-Grootenboer S, Caux F, Maubec E, Prost-Squarcioni C.

Front Med (Lausanne). 2018 Sep 27;5:268. doi: 10.3389/fmed.2018.00268. eCollection 2018.

12.

Is the Oral Disease Severity Score going to be useful for dermatologists when assessing pemphigus?

Murrell DF, Caux F, Prost-Squarcioni C.

Br J Dermatol. 2018 Oct;179(4):816-817. doi: 10.1111/bjd.16911. No abstract available.

PMID:
30318808
13.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

14.

Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

Gaudin O, Seta V, Alexandre M, Bohelay G, Aucouturier F, Mignot-Grootenboer S, Ingen-Housz-Oro S, Bernardeschi C, Schneider P, Mellottee B, Caux F, Prost-Squarcioni C.

Front Immunol. 2018 May 24;9:1030. doi: 10.3389/fimmu.2018.01030. eCollection 2018.

15.

Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.

Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakaş A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM Jr, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP.

J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30207-X. doi: 10.1016/j.jaad.2018.02.021. [Epub ahead of print]

16.

International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.

Prost-Squarcioni C, Caux F, Schmidt E, Jonkman MF, Vassileva S, Kim SC, Iranzo P, Daneshpazhooh M, Terra J, Bauer J, Fairley J, Hall R, Hertl M, Lehman JS, Marinovic B, Patsatsi A, Zillikens D; International Bullous Diseases Group, Werth V, Woodley DT, Murrell DF.

Br J Dermatol. 2018 Jul;179(1):30-41. doi: 10.1111/bjd.16138. Epub 2018 May 8.

PMID:
29165796
17.

Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.

Bal E, Park HS, Belaid-Choucair Z, Kayserili H, Naville M, Madrange M, Chiticariu E, Hadj-Rabia S, Cagnard N, Kuonen F, Bachmann D, Huber M, Le Gall C, Côté F, Hanein S, Rosti RÖ, Aslanger AD, Waisfisz Q, Bodemer C, Hermine O, Morice-Picard F, Labeille B, Caux F, Mazereeuw-Hautier J, Philip N, Levy N, Taieb A, Avril MF, Headon DJ, Gyapay G, Magnaldo T, Fraitag S, Crollius HR, Vabres P, Hohl D, Munnich A, Smahi A.

Nat Med. 2017 Oct;23(10):1226-1233. doi: 10.1038/nm.4368. Epub 2017 Sep 4.

18.

A case of a focal oedematous reaction induced by rituximab overlying lupus erythematosus tumidus.

Bohelay G, Rousset L, Levy A, Arana R, Laroche L, Caux F.

Eur J Dermatol. 2017 Oct 1;27(5):542-543. doi: 10.1684/ejd.2017.3072. No abstract available.

PMID:
28691689
19.

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D.

JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162. Erratum in: JAMA Dermatol. 2017 Aug 1;153(8):837.

20.

Insertion of Alu elements at a PTEN hotspot in Cowden syndrome.

Crivelli L, Bubien V, Jones N, Chiron J, Bonnet F, Barouk-Simonet E, Couzigou P, Sevenet N, Caux F, Longy M.

Eur J Hum Genet. 2017 Sep;25(9):1087-1091. doi: 10.1038/ejhg.2017.81. Epub 2017 May 17.

21.

Diagnosis in France of a Non-Toxigenic tox Gene-Bearing Strain of Corynebacterium diphtheriae in a Young Male Back From Senegal.

Billard-Pomares T, Rouyer C, Walewski V, Badell-Ocando E, Dumas M, Zumelzu C, Jaureguy F, Brisse S, Caux F, Bouchaud O, Carbonnelle E.

Open Forum Infect Dis. 2017 Jan 9;4(1):ofw271. doi: 10.1093/ofid/ofw271. eCollection 2017 Winter.

22.

Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid.

Zehou O, Raynaud JJ, Le Roux-Villet C, Alexandre M, Airinei G, Pascal F, Heller M, Lièvre N, Laroche L, Caux F, Benamouzig R, Prost-Squarcioni C.

Br J Dermatol. 2017 Oct;177(4):1074-1085. doi: 10.1111/bjd.15592. Epub 2017 Oct 1.

PMID:
28417469
23.

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.

Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases.

Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22.

PMID:
28342637
24.

Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults.

Gottlieb J, Ingen-Housz-Oro S, Alexandre M, Grootenboer-Mignot S, Aucouturier F, Sbidian E, Tancrede E, Schneider P, Regnier E, Picard-Dahan C, Begon E, Pauwels C, Cury K, Hüe S, Bernardeschi C, Ortonne N, Caux F, Wolkenstein P, Chosidow O, Prost-Squarcioni C.

Br J Dermatol. 2017 Jul;177(1):212-222. doi: 10.1111/bjd.15244. Epub 2017 May 15.

PMID:
27995619
25.

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology.

Ahmed AR, Carrozzo M, Caux F, Cirillo N, Dmochowski M, Alonso AE, Gniadecki R, Hertl M, López-Zabalza MJ, Lotti R, Pincelli C, Pittelkow M, Schmidt E, Sinha AA, Sprecher E, Grando SA.

Exp Dermatol. 2016 Nov;25(11):839-846. doi: 10.1111/exd.13106. Review.

PMID:
27305362
26.

Subcutaneous phaeohyphomycosis caused by Exophiala spinifera in a European patient with lymphoma: a rare occurrence case report and literature review.

Bohelay G, Robert S, Bouges-Michel C, Gerin M, Levy A, Fain O, Caux F.

Mycoses. 2016 Nov;59(11):691-696. doi: 10.1111/myc.12515. Review.

PMID:
27456474
27.

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.

Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N.

Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x.

28.

Hereditary angioedema with F12 mutation: first report of three cases associated with immune disorders.

Gallais Sérézal IR, Dhôte R, Caux F, Mèkinian A, Fain O.

Clin Med (Lond). 2016 Apr;16(2):206. doi: 10.7861/clinmedicine.16-2-206. No abstract available.

29.

Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA).

Seta V, Aucouturier F, Bonnefoy J, Le Roux-Villet C, Pendaries V, Alexandre M, Grootenboer-Mignot S, Heller M, Lièvre N, Laroche L, Caux F, Titeux M, Hovnanian A, Prost-Squarcioni C.

J Am Acad Dermatol. 2016 Jun;74(6):1166-72. doi: 10.1016/j.jaad.2016.01.005. Epub 2016 Mar 3.

PMID:
26947449
30.

Journées dermatologiques de Paris 2015.

Caux F; comité de sélection.

Ann Dermatol Venereol. 2015 Dec;142(12 Suppl):S373-5. doi: 10.1016/j.annder.2015.11.001. French. No abstract available.

PMID:
26616838
31.

Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013.

Sbidian E, Hotz C, Seneschal J, Maruani A, Amelot F, Aubin F, Paul C, Beylot Barry M, Humbert P, Dupuy A, Caux F, Dupin N, Modiano P, Lepesant P, Ingen-Housz-Oro S, Mahé E, Bachelez H, Chosidow O, Wolkenstein P.

Br J Dermatol. 2016 Mar;174(3):667-70. doi: 10.1111/bjd.14199. Epub 2015 Dec 22. No abstract available.

32.

Systemic granulomatosis and polyarthritis with pitting edema in B-chronic lymphocytic leukemia.

Grignano E, Mekinian A, Caux F, Soussan M, Cymbalista F, Fain O.

Joint Bone Spine. 2015 Jul;82(4):294-5. doi: 10.1016/j.jbspin.2014.10.017. Epub 2015 Jan 24. No abstract available.

PMID:
25630615
33.

[Dermatology Days, Paris, 2014].

Caux F.

Ann Dermatol Venereol. 2014 Dec;141(12 Suppl):S185-7. doi: 10.1016/j.annder.2014.11.001. Epub 2014 Nov 6. French. No abstract available.

PMID:
25457186
34.

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP.

J Am Acad Dermatol. 2015 Jan;72(1):168-74. doi: 10.1016/j.jaad.2014.08.024. Epub 2014 Nov 4. Review.

35.

[Hypocomplementemic urticarial vasculitis syndrome].

Melboucy-Belkhir S, Glitho S, Caux F, Mekinian A, Fain O.

Rev Prat. 2014 Jan;64(1):25. French. No abstract available.

PMID:
24649538
36.

[Pemphigoid gestationis].

Gras J, Morin AS, Caux F, Mekinian A, Fain O.

Rev Prat. 2013 Nov;63(9):1208. French. No abstract available.

PMID:
24422286
37.

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Colliou N, Picard D, Caillot F, Calbo S, Le Corre S, Lim A, Lemercier B, Le Mauff B, Maho-Vaillant M, Jacquot S, Bedane C, Bernard P, Caux F, Prost C, Delaporte E, Doutre MS, Dreno B, Franck N, Ingen-Housz-Oro S, Chosidow O, Pauwels C, Picard C, Roujeau JC, Sigal M, Tancrede-Bohin E, Templier I, Eming R, Hertl M, D'Incan M, Joly P, Musette P.

Sci Transl Med. 2013 Mar 6;5(175):175ra30. doi: 10.1126/scitranslmed.3005166.

38.

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.

Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, Edery P, Bottani A, Layet V, Caron O, Gilbert-Dussardier B, Delnatte C, Dugast C, Fricker JP, Bonneau D, Sevenet N, Longy M, Caux F; French Cowden Disease Network.

J Med Genet. 2013 Apr;50(4):255-63. doi: 10.1136/jmedgenet-2012-101339. Epub 2013 Jan 18.

PMID:
23335809
39.

Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita.

Baroudjian B, Le Roux-Villet C, Bréchignac S, Alexandre M, Caux F, Prost-Squarcioni C, Laroche L.

Eur J Dermatol. 2012 Nov-Dec;22(6):795-7. doi: 10.1684/ejd.2012.1840. No abstract available.

PMID:
23228865
40.

Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.

Munyangango EM, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lièvre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C.

Br J Dermatol. 2013 Feb;168(2):381-90. doi: 10.1111/bjd.12041.

PMID:
22963186
41.

[Unilateral purpura of a limb revealing a periprosthetic abscess in an HIV-infected patient].

Zumelzu C, Alexandre M, Blom A, Levy A, Laroche L, Caux F.

Ann Dermatol Venereol. 2011 Nov;138(11):748-52. doi: 10.1016/j.annder.2011.06.010. Epub 2011 Aug 17. French.

PMID:
22078036
42.

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP.

J Am Acad Dermatol. 2012 Mar;66(3):479-85. doi: 10.1016/j.jaad.2011.06.032. Epub 2011 Nov 5.

43.

Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita.

Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lièvre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C.

J Invest Dermatol. 2011 Dec;131(12):2386-93. doi: 10.1038/jid.2011.231. Epub 2011 Aug 11.

44.

Diagnosis and clinical features of epidermolysis bullosa acquisita.

Caux F.

Dermatol Clin. 2011 Jul;29(3):485-91, x. doi: 10.1016/j.det.2011.03.017. Review.

PMID:
21605816
45.

Endoscopic findings in Cowden syndrome.

Coriat R, Mozer M, Caux F, Chryssostalis A, Terris B, Grandjouan S, Benamouzig R, Martin A, Chaussade S.

Endoscopy. 2011 Aug;43(8):723-6. doi: 10.1055/s-0030-1256342. Epub 2011 Mar 24. Erratum in: Endoscopy. 2011 Dec;43(12):1096. Caux, E [corrected to Caux, F].

PMID:
21437855
46.

Rituximab for patients with refractory mucous membrane pemphigoid.

Le Roux-Villet C, Prost-Squarcioni C, Alexandre M, Caux F, Pascal F, Doan S, Brette MD, Soued I, Gabison É, Aucouturier F, Letestu R, Laroche L, Bachelez H.

Arch Dermatol. 2011 Jul;147(7):843-9. doi: 10.1001/archdermatol.2011.54. Epub 2011 Mar 21.

PMID:
21422323
47.

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.

Gardie B, Remenieras A, Kattygnarath D, Bombled J, Lefèvre S, Perrier-Trudova V, Rustin P, Barrois M, Slama A, Avril MF, Bessis D, Caron O, Caux F, Collignon P, Coupier I, Cremin C, Dollfus H, Dugast C, Escudier B, Faivre L, Field M, Gilbert-Dussardier B, Janin N, Leport Y, Leroux D, Lipsker D, Malthieu F, McGilliwray B, Maugard C, Méjean A, Mortemousque I, Plessis G, Poppe B, Pruvost-Balland C, Rooker S, Roume J, Soufir N, Steinraths M, Tan MH, Théodore C, Thomas L, Vabres P, Van Glabeke E, Meric JB, Verkarre V, Lenoir G, Joulin V, Deveaux S, Cusin V, Feunteun J, Teh BT, Bressac-de Paillerets B, Richard S; French National Cancer Institute "Inherited predisposition to kidney cancer" network.

J Med Genet. 2011 Apr;48(4):226-34. doi: 10.1136/jmg.2010.085068. Epub 2011 Mar 12. Erratum in: J Med Genet. 2011 Aug;48(8):576.

48.

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M.

Breast Cancer Res. 2010;12(4):R63. doi: 10.1186/bcr2626. Epub 2010 Aug 16.

49.

[Epidermolysis bullosa acquisita].

Caux F.

Presse Med. 2010 Oct;39(10):1081-8. doi: 10.1016/j.lpm.2010.04.021. Epub 2010 Aug 1. French.

PMID:
20674256
50.

Unmasking leprosy: an unusual immune reconstitution inflammatory syndrome in a patient infected with human immunodeficiency virus.

Bussone G, Charlier C, Bille E, Caux F, Lévy A, Viard JP, Lecuit M, Lortholary O.

Am J Trop Med Hyg. 2010 Jul;83(1):13-4. doi: 10.4269/ajtmh.2010.10-0071.

Supplemental Content

Support Center